Dr. Chou discussing his poster at AACR

Both Dr. Jeffrey Chou and Dr. Yaguang Xi presented research posters at the American Association for Cancer Research annual meeting in Washington this week.

Dr. Chou is the 2009 Lisa Dubow Research Fellow, and Dr. Xi received the award in 2008.

Dr. Xi’s research found a micro-RNA (miRNA) that made colorectal cancer cells more sensitive to 5-FU and also predicted which cells, and potentially which patients, response best to treatment with 5-FU.

Dr. Chou studied whether treating colorectal cancer cells with decitabine (DAC) could produce cancer-testis antigen in the cells and make them sensitive to immunotherapy. Read the rest of this entry »

If you have completed your colorectal cancer treatment within the past two years, researchers at the University of Texas need your help.

Led by Nynikka Palmer, a doctoral student at the University of Texas School of Public Health, a study will explore the goals and plans colorectal cancer survivors have for their health after their treatment is over.

Learn more about the survey or sign up. Read the rest of this entry »

C3 Board Chair Nancy Roach and C3 staffer Kate Murphy and were part of the Scientist-Survivor Program at the American Association for Cancer Research 101st Annual Meeting in Washington this week.

Nancy was a mentor for a group of patient advocates who were attending AACR .  For Kate this was a third AACR Annual Meeting.  She presented a poster about C3 and its work.

This year’s meeting theme Conquering Cancer Through Discovery Research led to more than 700 presentations and 6,500 posters presenting key basic and translational research. Read the rest of this entry »

Rona Yaeger MD

Rona Yaeger, MD is the 2010 Lisa Dubow Research Fellow, receiving the 2010 American Association for Cancer Research – Colorectal Cancer Coalition Fellows Grant.

The Award will be made tonight at a special dinner in honor of AACR Fellows Fund grantees.

Dr. Yaeger is from Memorial Sloan-Kettering Cancer Center in New York.  Her grant research will focus on inhibiting the AKT pathway in colorectal cancer cells. Read the rest of this entry »

In a surprising results, doctors studying surgical complications and hospital deaths after colorectal surgery found that diabetic patients do better than non-diabetics after surgery.

There was a 23 percent reduction in deaths after surgery for diabetics and 18 percent fewer complications.

Unfortunately, this improvement in outcomes did not extend to the uninsured or to people under 50. Read the rest of this entry »